• Sign up
  • Login

Scheme Profile

SBI Healthcare Opportunities Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
2,626
Inception Date
31-12-2004
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 350.1172 (08-Apr-2024) / 225.3867 (02-May-2023)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 344.41 ( 0.76) ( 0.22 %)
  • Benchmark
  • S&P BSE Healthcare TRI
  • Fund Manager
  • Tanmaya Desai
  • Value of () 1,00,000 since inception
  • 15,59,106
  • Entry Load
  • NIL
  • Exit Load
  • 0.50% - If redeemed/switched out wihin 15 days from the date of allotment. Nil - If redeemed/switched out after 15 days from the date of allotment.
  • Expense Ratio (%)
  • 2.37
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 48.36 times
  • Portfolio P/B
  • 7.25 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.43

Risk Factors

  • Jenson's Alpha
  • 2.60
  • Standard Deviation
  • 4.24
  • Beta
  • 0.89
  • Sharpe
  • 0.94
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.53

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • S&P BSE Healthcare TRI
  • 12.07
  • 7.21
  • 31.61
  • 57.20
  • 15.97
  • 20.48
  • 13.33
  • -

Company Top 5 Holdings

  [ As on 31 Mar 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceuticals Industries Ltd
  • Equity
  • 24,00,000
  • 14.81
  • Cipla Ltd
  • Equity
  • 13,20,000
  • 7.52
  • Max Healthcare Institute Ltd
  • Equity
  • 22,00,000
  • 6.87
  • Mankind Pharma Ltd
  • Equity
  • 6,00,000
  • 5.26
  • Lonza Group
  • Foreign Equity
  • 2,50,000
  • 4.75

Sector Top 5 Holdings

  [ As on 31 Mar 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,01,56,000
  • 64.40
  • Healthcare
  • 91,21,547
  • 31.17
  • Chemicals
  • 14,00,000
  • 4.43

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 11.92 10.31 12.07 2.02 2,626.34
2023 38.25 31.12 38.35 18.10 2,263.22
2022 -5.78 -9.58 -11.31 2.80 1,660.46
2021 19.03 17.96 20.57 21.69 1,942.51
2020 65.28 65.84 62.19 15.60 1,575.33
2019 -0.63 4.22 -3.06 13.79 926.47
2018 -9.90 -2.00 -5.45 6.67 1,045.43
2017 1.49 4.69 0.53 28.06 1,132.62
2016 -14.20 -12.31 -12.63 1.78 1,006.68
2015 26.99 13.13 15.78 -5.05 958.37

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Mar-2024 11.47 9.70 10.84 1.91 2,626.34
Dec-2023 9.32 11.42 11.01 10.27 2,263.22
Sep-2023 9.58 11.39 11.65 0.96 2,059.99
Jun-2023 19.34 15.61 17.79 9.49 1,843.35

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close